1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Untreated Resectable Pancreatic Adenocarcinoma: new trials by email Literature Review of Untreated Resectable Pancreatic Adenocarcinoma trials Research Report on Untreated Resectable Pancreatic Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer Paclitaxel protein bound, Gemcitabine, Cisplatin - Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma | Phase 2 | Completed | HonorHealth Research Institute | 19 | 2020-12-01 | 2026-07-21 |
Cisplatin (1) · Gemcitabine (1) · Hydroxychloroquine (1) · Taxes (1)
HonorHealth Research Institute (1)
United States (1)